Cargando…
Antibody and T Cell Responses in Reciprocal Prime-Boost Studies with Full-Length and Truncated Merozoite Surface Protein 1–42 Vaccines
The P. falciparum Merozoite Surface Protein 1–42 (MSP1-42) is one of the most studied malaria subunit vaccine candidates. The N-terminal fragment of MSP1-42, MSP1-33, is primarily composed of allelic sequences, and has been shown to possess T helper epitopes that influence protective antibody respon...
Autores principales: | Pusic, Kae, Clements, Danielle, Kobuch, Sophie, Hui, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3786974/ https://www.ncbi.nlm.nih.gov/pubmed/24098747 http://dx.doi.org/10.1371/journal.pone.0075939 |
Ejemplares similares
-
Immunization with full-length Plasmodium falciparum merozoite surface protein 1 is safe and elicits functional cytophilic antibodies in a randomized first-in-human trial
por: Blank, Antje, et al.
Publicado: (2020) -
Immunogenicity of bacterial-expressed recombinant Plasmodium knowlesi merozoite surface protein-1(42) (MSP-1(42))
por: Cheong, Fei Wen, et al.
Publicado: (2013) -
Co-expression of truncated and full-length tau induces severe neurotoxicity
por: Ozcelik, S, et al.
Publicado: (2016) -
Boosting antibody responses to Plasmodium falciparum merozoite antigens in children with highly seasonal exposure to infection
por: AKPOGHENETA, O J, et al.
Publicado: (2010) -
Comparative Immunogenicities of Full-Length Plasmodium falciparum Merozoite Surface Protein 3 and a 24-Kilodalton N-Terminal Fragment
por: Imam, Marvam, et al.
Publicado: (2012)